nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—CYP3A7—Vincristine—sarcoma	0.0871	0.17	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0871	0.17	CbGbCtD
Zalcitabine—CYP3A4—Thiotepa—sarcoma	0.0861	0.168	CbGbCtD
Zalcitabine—CYP3A5—Vincristine—sarcoma	0.0653	0.128	CbGbCtD
Zalcitabine—CYP3A5—Etoposide—sarcoma	0.0598	0.117	CbGbCtD
Zalcitabine—CYP3A4—Mitoxantrone—sarcoma	0.037	0.0723	CbGbCtD
Zalcitabine—CYP3A4—Vincristine—sarcoma	0.0255	0.0497	CbGbCtD
Zalcitabine—CYP2D6—Doxorubicin—sarcoma	0.025	0.0489	CbGbCtD
Zalcitabine—CYP3A4—Etoposide—sarcoma	0.0233	0.0456	CbGbCtD
Zalcitabine—CYP3A4—Doxorubicin—sarcoma	0.0159	0.0311	CbGbCtD
Zalcitabine—DCK—Doxorubicin—Epirubicin—sarcoma	0.0033	0.519	CbGdCrCtD
Zalcitabine—DCK—Epirubicin—Doxorubicin—sarcoma	0.00305	0.481	CbGdCrCtD
Zalcitabine—CYP3A43—testis—sarcoma	0.00302	0.0519	CbGeAlD
Zalcitabine—SLC29A1—mammary gland—sarcoma	0.00289	0.0497	CbGeAlD
Zalcitabine—CYP3A43—liver—sarcoma	0.00286	0.0491	CbGeAlD
Zalcitabine—SLC29A2—cardiac atrium—sarcoma	0.0027	0.0463	CbGeAlD
Zalcitabine—SLC29A2—tendon—sarcoma	0.00235	0.0404	CbGeAlD
Zalcitabine—SLC29A1—myometrium—sarcoma	0.00205	0.0352	CbGeAlD
Zalcitabine—DCK—myometrium—sarcoma	0.00196	0.0337	CbGeAlD
Zalcitabine—DCK—embryo—sarcoma	0.00189	0.0324	CbGeAlD
Zalcitabine—SLC29A2—liver—sarcoma	0.00184	0.0316	CbGeAlD
Zalcitabine—DCK—seminal vesicle—sarcoma	0.00177	0.0304	CbGeAlD
Zalcitabine—SLC29A1—hematopoietic system—sarcoma	0.00176	0.0303	CbGeAlD
Zalcitabine—SLC29A1—connective tissue—sarcoma	0.0017	0.0291	CbGeAlD
Zalcitabine—DCK—hematopoietic system—sarcoma	0.00168	0.0289	CbGeAlD
Zalcitabine—SLC29A2—lymph node—sarcoma	0.00141	0.0242	CbGeAlD
Zalcitabine—CYP2C9—mammary gland—sarcoma	0.00141	0.0242	CbGeAlD
Zalcitabine—SLC29A1—cardiac atrium—sarcoma	0.00134	0.023	CbGeAlD
Zalcitabine—SLC29A1—uterus—sarcoma	0.00133	0.0229	CbGeAlD
Zalcitabine—CYP3A7—liver—sarcoma	0.00128	0.022	CbGeAlD
Zalcitabine—DCK—cardiac atrium—sarcoma	0.00128	0.022	CbGeAlD
Zalcitabine—DCK—uterus—sarcoma	0.00127	0.0218	CbGeAlD
Zalcitabine—SLC22A7—testis—sarcoma	0.00125	0.0215	CbGeAlD
Zalcitabine—SLC29A1—lymphoid tissue—sarcoma	0.00124	0.0213	CbGeAlD
Zalcitabine—DCK—lymphoid tissue—sarcoma	0.00119	0.0204	CbGeAlD
Zalcitabine—SLC22A7—liver—sarcoma	0.00118	0.0203	CbGeAlD
Zalcitabine—SLC29A1—tendon—sarcoma	0.00117	0.02	CbGeAlD
Zalcitabine—SLC29A1—bone marrow—sarcoma	0.00113	0.0194	CbGeAlD
Zalcitabine—DCK—tendon—sarcoma	0.00111	0.0191	CbGeAlD
Zalcitabine—CYP3A7-CYP3A51P—liver—sarcoma	0.00109	0.0187	CbGeAlD
Zalcitabine—DCK—bone marrow—sarcoma	0.00108	0.0185	CbGeAlD
Zalcitabine—SLC29A1—testis—sarcoma	0.000966	0.0166	CbGeAlD
Zalcitabine—DCK—testis—sarcoma	0.000923	0.0158	CbGeAlD
Zalcitabine—SLC29A1—liver—sarcoma	0.000913	0.0157	CbGeAlD
Zalcitabine—DCK—liver—sarcoma	0.000873	0.015	CbGeAlD
Zalcitabine—CYP3A5—hematopoietic system—sarcoma	0.000872	0.015	CbGeAlD
Zalcitabine—CYP2C9—hematopoietic system—sarcoma	0.000858	0.0147	CbGeAlD
Zalcitabine—SLC29A1—lymph node—sarcoma	0.0007	0.012	CbGeAlD
Zalcitabine—DCK—lymph node—sarcoma	0.000669	0.0115	CbGeAlD
Zalcitabine—CYP3A4—hematopoietic system—sarcoma	0.000654	0.0112	CbGeAlD
Zalcitabine—CYP2D6—hematopoietic system—sarcoma	0.000644	0.0111	CbGeAlD
Zalcitabine—CYP3A5—liver—sarcoma	0.000452	0.00776	CbGeAlD
Zalcitabine—CYP2C9—liver—sarcoma	0.000445	0.00763	CbGeAlD
Zalcitabine—Convulsion—Etoposide—sarcoma	0.000434	0.00103	CcSEcCtD
Zalcitabine—Hyponatraemia—Doxorubicin—sarcoma	0.000434	0.00102	CcSEcCtD
Zalcitabine—Dyspepsia—Mitoxantrone—sarcoma	0.000433	0.00102	CcSEcCtD
Zalcitabine—Hypertension—Etoposide—sarcoma	0.000433	0.00102	CcSEcCtD
Zalcitabine—Pain—Vincristine—sarcoma	0.000432	0.00102	CcSEcCtD
Zalcitabine—Osteoarthritis—Doxorubicin—sarcoma	0.000432	0.00102	CcSEcCtD
Zalcitabine—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000432	0.00102	CcSEcCtD
Zalcitabine—Pain in extremity—Doxorubicin—sarcoma	0.000432	0.00102	CcSEcCtD
Zalcitabine—Dry skin—Epirubicin—sarcoma	0.000428	0.00101	CcSEcCtD
Zalcitabine—Decreased appetite—Mitoxantrone—sarcoma	0.000428	0.00101	CcSEcCtD
Zalcitabine—Abdominal pain upper—Epirubicin—sarcoma	0.000426	0.00101	CcSEcCtD
Zalcitabine—Affect lability—Doxorubicin—sarcoma	0.000425	0.001	CcSEcCtD
Zalcitabine—Migraine—Doxorubicin—sarcoma	0.000425	0.001	CcSEcCtD
Zalcitabine—Hypokalaemia—Epirubicin—sarcoma	0.000425	0.001	CcSEcCtD
Zalcitabine—Fatigue—Mitoxantrone—sarcoma	0.000424	0.001	CcSEcCtD
Zalcitabine—Discomfort—Etoposide—sarcoma	0.000422	0.000996	CcSEcCtD
Zalcitabine—Pain—Mitoxantrone—sarcoma	0.000421	0.000994	CcSEcCtD
Zalcitabine—Hypersensitivity—Thiotepa—sarcoma	0.00042	0.000992	CcSEcCtD
Zalcitabine—Nasopharyngitis—Epirubicin—sarcoma	0.000417	0.000986	CcSEcCtD
Zalcitabine—Hypersensitivity—Dactinomycin—sarcoma	0.000417	0.000984	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Vincristine—sarcoma	0.000413	0.000976	CcSEcCtD
Zalcitabine—Gastritis—Epirubicin—sarcoma	0.000413	0.000976	CcSEcCtD
Zalcitabine—Confusional state—Etoposide—sarcoma	0.000413	0.000975	CcSEcCtD
Zalcitabine—Muscular weakness—Epirubicin—sarcoma	0.000412	0.000972	CcSEcCtD
Zalcitabine—Mood swings—Doxorubicin—sarcoma	0.000409	0.000966	CcSEcCtD
Zalcitabine—Asthenia—Thiotepa—sarcoma	0.000409	0.000966	CcSEcCtD
Zalcitabine—Infection—Etoposide—sarcoma	0.000407	0.00096	CcSEcCtD
Zalcitabine—Abdominal distension—Epirubicin—sarcoma	0.000406	0.000959	CcSEcCtD
Zalcitabine—Ataxia—Doxorubicin—sarcoma	0.000406	0.000959	CcSEcCtD
Zalcitabine—Asthenia—Dactinomycin—sarcoma	0.000406	0.000958	CcSEcCtD
Zalcitabine—Feeling abnormal—Mitoxantrone—sarcoma	0.000405	0.000958	CcSEcCtD
Zalcitabine—Blood creatinine increased—Doxorubicin—sarcoma	0.000405	0.000956	CcSEcCtD
Zalcitabine—Dysphagia—Epirubicin—sarcoma	0.000403	0.000953	CcSEcCtD
Zalcitabine—Pruritus—Thiotepa—sarcoma	0.000403	0.000952	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000402	0.00095	CcSEcCtD
Zalcitabine—Thrombocytopenia—Etoposide—sarcoma	0.000401	0.000946	CcSEcCtD
Zalcitabine—Tachycardia—Etoposide—sarcoma	0.000399	0.000943	CcSEcCtD
Zalcitabine—Eosinophilia—Epirubicin—sarcoma	0.000399	0.000943	CcSEcCtD
Zalcitabine—Body temperature increased—Vincristine—sarcoma	0.000399	0.000943	CcSEcCtD
Zalcitabine—Abdominal pain—Vincristine—sarcoma	0.000399	0.000943	CcSEcCtD
Zalcitabine—Skin disorder—Etoposide—sarcoma	0.000398	0.000939	CcSEcCtD
Zalcitabine—Dry skin—Doxorubicin—sarcoma	0.000396	0.000935	CcSEcCtD
Zalcitabine—Hyperhidrosis—Etoposide—sarcoma	0.000396	0.000935	CcSEcCtD
Zalcitabine—Pancreatitis—Epirubicin—sarcoma	0.000396	0.000934	CcSEcCtD
Zalcitabine—Abdominal pain upper—Doxorubicin—sarcoma	0.000394	0.000932	CcSEcCtD
Zalcitabine—Hypokalaemia—Doxorubicin—sarcoma	0.000393	0.000928	CcSEcCtD
Zalcitabine—Urticaria—Mitoxantrone—sarcoma	0.000391	0.000923	CcSEcCtD
Zalcitabine—Anorexia—Etoposide—sarcoma	0.00039	0.000921	CcSEcCtD
Zalcitabine—Diarrhoea—Thiotepa—sarcoma	0.00039	0.000921	CcSEcCtD
Zalcitabine—Abdominal pain—Mitoxantrone—sarcoma	0.000389	0.000919	CcSEcCtD
Zalcitabine—Body temperature increased—Mitoxantrone—sarcoma	0.000389	0.000919	CcSEcCtD
Zalcitabine—Diarrhoea—Dactinomycin—sarcoma	0.000387	0.000914	CcSEcCtD
Zalcitabine—Nasopharyngitis—Doxorubicin—sarcoma	0.000386	0.000912	CcSEcCtD
Zalcitabine—Gastritis—Doxorubicin—sarcoma	0.000382	0.000903	CcSEcCtD
Zalcitabine—Muscular weakness—Doxorubicin—sarcoma	0.000381	0.0009	CcSEcCtD
Zalcitabine—Neutropenia—Epirubicin—sarcoma	0.000377	0.000891	CcSEcCtD
Zalcitabine—Dysuria—Epirubicin—sarcoma	0.000377	0.000891	CcSEcCtD
Zalcitabine—Dizziness—Thiotepa—sarcoma	0.000377	0.00089	CcSEcCtD
Zalcitabine—Abdominal distension—Doxorubicin—sarcoma	0.000376	0.000888	CcSEcCtD
Zalcitabine—Dysphagia—Doxorubicin—sarcoma	0.000373	0.000882	CcSEcCtD
Zalcitabine—Pollakiuria—Epirubicin—sarcoma	0.000373	0.00088	CcSEcCtD
Zalcitabine—Hypersensitivity—Vincristine—sarcoma	0.000372	0.000879	CcSEcCtD
Zalcitabine—Eosinophilia—Doxorubicin—sarcoma	0.00037	0.000873	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Epirubicin—sarcoma	0.000368	0.00087	CcSEcCtD
Zalcitabine—Pancreatitis—Doxorubicin—sarcoma	0.000366	0.000864	CcSEcCtD
Zalcitabine—Weight decreased—Epirubicin—sarcoma	0.000365	0.000862	CcSEcCtD
Zalcitabine—Dyspnoea—Etoposide—sarcoma	0.000365	0.000862	CcSEcCtD
Zalcitabine—Hyperglycaemia—Epirubicin—sarcoma	0.000364	0.00086	CcSEcCtD
Zalcitabine—Somnolence—Etoposide—sarcoma	0.000364	0.000859	CcSEcCtD
Zalcitabine—Hypersensitivity—Mitoxantrone—sarcoma	0.000362	0.000856	CcSEcCtD
Zalcitabine—Asthenia—Vincristine—sarcoma	0.000362	0.000856	CcSEcCtD
Zalcitabine—Vomiting—Thiotepa—sarcoma	0.000362	0.000856	CcSEcCtD
Zalcitabine—Vomiting—Dactinomycin—sarcoma	0.00036	0.000849	CcSEcCtD
Zalcitabine—Rash—Thiotepa—sarcoma	0.000359	0.000849	CcSEcCtD
Zalcitabine—Dermatitis—Thiotepa—sarcoma	0.000359	0.000848	CcSEcCtD
Zalcitabine—Headache—Thiotepa—sarcoma	0.000357	0.000843	CcSEcCtD
Zalcitabine—Rash—Dactinomycin—sarcoma	0.000357	0.000842	CcSEcCtD
Zalcitabine—Decreased appetite—Etoposide—sarcoma	0.000356	0.00084	CcSEcCtD
Zalcitabine—Asthenia—Mitoxantrone—sarcoma	0.000353	0.000834	CcSEcCtD
Zalcitabine—CYP2D6—testis—sarcoma	0.000353	0.00606	CbGeAlD
Zalcitabine—Fatigue—Etoposide—sarcoma	0.000353	0.000833	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Epirubicin—sarcoma	0.000353	0.000833	CcSEcCtD
Zalcitabine—Jaundice—Epirubicin—sarcoma	0.000351	0.000828	CcSEcCtD
Zalcitabine—Pain—Etoposide—sarcoma	0.00035	0.000827	CcSEcCtD
Zalcitabine—Dysuria—Doxorubicin—sarcoma	0.000349	0.000824	CcSEcCtD
Zalcitabine—Neutropenia—Doxorubicin—sarcoma	0.000349	0.000824	CcSEcCtD
Zalcitabine—Diarrhoea—Vincristine—sarcoma	0.000346	0.000817	CcSEcCtD
Zalcitabine—Pollakiuria—Doxorubicin—sarcoma	0.000345	0.000814	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Doxorubicin—sarcoma	0.000341	0.000805	CcSEcCtD
Zalcitabine—Epistaxis—Epirubicin—sarcoma	0.000339	0.000801	CcSEcCtD
Zalcitabine—CYP3A4—liver—sarcoma	0.000339	0.00582	CbGeAlD
Zalcitabine—Weight decreased—Doxorubicin—sarcoma	0.000338	0.000798	CcSEcCtD
Zalcitabine—Sinusitis—Epirubicin—sarcoma	0.000337	0.000797	CcSEcCtD
Zalcitabine—Feeling abnormal—Etoposide—sarcoma	0.000337	0.000797	CcSEcCtD
Zalcitabine—Hyperglycaemia—Doxorubicin—sarcoma	0.000337	0.000795	CcSEcCtD
Zalcitabine—Diarrhoea—Mitoxantrone—sarcoma	0.000337	0.000795	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Etoposide—sarcoma	0.000335	0.00079	CcSEcCtD
Zalcitabine—Dizziness—Vincristine—sarcoma	0.000334	0.000789	CcSEcCtD
Zalcitabine—CYP2D6—liver—sarcoma	0.000334	0.00573	CbGeAlD
Zalcitabine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000326	0.000771	CcSEcCtD
Zalcitabine—Urticaria—Etoposide—sarcoma	0.000325	0.000768	CcSEcCtD
Zalcitabine—Jaundice—Doxorubicin—sarcoma	0.000324	0.000766	CcSEcCtD
Zalcitabine—Rhinitis—Epirubicin—sarcoma	0.000324	0.000765	CcSEcCtD
Zalcitabine—Abdominal pain—Etoposide—sarcoma	0.000324	0.000764	CcSEcCtD
Zalcitabine—Body temperature increased—Etoposide—sarcoma	0.000324	0.000764	CcSEcCtD
Zalcitabine—Hepatitis—Epirubicin—sarcoma	0.000323	0.000763	CcSEcCtD
Zalcitabine—Vomiting—Vincristine—sarcoma	0.000321	0.000759	CcSEcCtD
Zalcitabine—Pharyngitis—Epirubicin—sarcoma	0.00032	0.000757	CcSEcCtD
Zalcitabine—Rash—Vincristine—sarcoma	0.000319	0.000752	CcSEcCtD
Zalcitabine—Dermatitis—Vincristine—sarcoma	0.000318	0.000752	CcSEcCtD
Zalcitabine—Headache—Vincristine—sarcoma	0.000316	0.000748	CcSEcCtD
Zalcitabine—Epistaxis—Doxorubicin—sarcoma	0.000314	0.000742	CcSEcCtD
Zalcitabine—Vomiting—Mitoxantrone—sarcoma	0.000313	0.000739	CcSEcCtD
Zalcitabine—Sinusitis—Doxorubicin—sarcoma	0.000312	0.000738	CcSEcCtD
Zalcitabine—Visual impairment—Epirubicin—sarcoma	0.000311	0.000735	CcSEcCtD
Zalcitabine—Rash—Mitoxantrone—sarcoma	0.00031	0.000733	CcSEcCtD
Zalcitabine—Dermatitis—Mitoxantrone—sarcoma	0.00031	0.000732	CcSEcCtD
Zalcitabine—Headache—Mitoxantrone—sarcoma	0.000308	0.000728	CcSEcCtD
Zalcitabine—Eye disorder—Epirubicin—sarcoma	0.000302	0.000713	CcSEcCtD
Zalcitabine—Hypersensitivity—Etoposide—sarcoma	0.000302	0.000712	CcSEcCtD
Zalcitabine—Tinnitus—Epirubicin—sarcoma	0.000301	0.000711	CcSEcCtD
Zalcitabine—Flushing—Epirubicin—sarcoma	0.0003	0.000708	CcSEcCtD
Zalcitabine—Rhinitis—Doxorubicin—sarcoma	0.0003	0.000708	CcSEcCtD
Zalcitabine—Hepatitis—Doxorubicin—sarcoma	0.000299	0.000706	CcSEcCtD
Zalcitabine—Pharyngitis—Doxorubicin—sarcoma	0.000297	0.0007	CcSEcCtD
Zalcitabine—Asthenia—Etoposide—sarcoma	0.000294	0.000694	CcSEcCtD
Zalcitabine—Chills—Epirubicin—sarcoma	0.00029	0.000684	CcSEcCtD
Zalcitabine—Pruritus—Etoposide—sarcoma	0.00029	0.000684	CcSEcCtD
Zalcitabine—Arrhythmia—Epirubicin—sarcoma	0.000288	0.000681	CcSEcCtD
Zalcitabine—Visual impairment—Doxorubicin—sarcoma	0.000288	0.00068	CcSEcCtD
Zalcitabine—Alopecia—Epirubicin—sarcoma	0.000285	0.000674	CcSEcCtD
Zalcitabine—Diarrhoea—Etoposide—sarcoma	0.00028	0.000661	CcSEcCtD
Zalcitabine—Eye disorder—Doxorubicin—sarcoma	0.000279	0.00066	CcSEcCtD
Zalcitabine—Tinnitus—Doxorubicin—sarcoma	0.000279	0.000658	CcSEcCtD
Zalcitabine—Flushing—Doxorubicin—sarcoma	0.000277	0.000655	CcSEcCtD
Zalcitabine—Flatulence—Epirubicin—sarcoma	0.000277	0.000654	CcSEcCtD
Zalcitabine—Tension—Epirubicin—sarcoma	0.000276	0.000652	CcSEcCtD
Zalcitabine—Dysgeusia—Epirubicin—sarcoma	0.000275	0.00065	CcSEcCtD
Zalcitabine—Nervousness—Epirubicin—sarcoma	0.000273	0.000645	CcSEcCtD
Zalcitabine—Back pain—Epirubicin—sarcoma	0.000272	0.000642	CcSEcCtD
Zalcitabine—Dizziness—Etoposide—sarcoma	0.000271	0.000639	CcSEcCtD
Zalcitabine—Muscle spasms—Epirubicin—sarcoma	0.00027	0.000638	CcSEcCtD
Zalcitabine—Chills—Doxorubicin—sarcoma	0.000268	0.000633	CcSEcCtD
Zalcitabine—Arrhythmia—Doxorubicin—sarcoma	0.000267	0.00063	CcSEcCtD
Zalcitabine—Vision blurred—Epirubicin—sarcoma	0.000265	0.000626	CcSEcCtD
Zalcitabine—Alopecia—Doxorubicin—sarcoma	0.000264	0.000624	CcSEcCtD
Zalcitabine—Ill-defined disorder—Epirubicin—sarcoma	0.000261	0.000616	CcSEcCtD
Zalcitabine—Vomiting—Etoposide—sarcoma	0.00026	0.000615	CcSEcCtD
Zalcitabine—Anaemia—Epirubicin—sarcoma	0.00026	0.000614	CcSEcCtD
Zalcitabine—Agitation—Epirubicin—sarcoma	0.000258	0.00061	CcSEcCtD
Zalcitabine—Rash—Etoposide—sarcoma	0.000258	0.00061	CcSEcCtD
Zalcitabine—Dermatitis—Etoposide—sarcoma	0.000258	0.000609	CcSEcCtD
Zalcitabine—Headache—Etoposide—sarcoma	0.000256	0.000606	CcSEcCtD
Zalcitabine—Flatulence—Doxorubicin—sarcoma	0.000256	0.000605	CcSEcCtD
Zalcitabine—Tension—Doxorubicin—sarcoma	0.000255	0.000603	CcSEcCtD
Zalcitabine—Dysgeusia—Doxorubicin—sarcoma	0.000255	0.000602	CcSEcCtD
Zalcitabine—Malaise—Epirubicin—sarcoma	0.000253	0.000599	CcSEcCtD
Zalcitabine—Nervousness—Doxorubicin—sarcoma	0.000253	0.000597	CcSEcCtD
Zalcitabine—Vertigo—Epirubicin—sarcoma	0.000253	0.000597	CcSEcCtD
Zalcitabine—Syncope—Epirubicin—sarcoma	0.000252	0.000595	CcSEcCtD
Zalcitabine—Leukopenia—Epirubicin—sarcoma	0.000252	0.000594	CcSEcCtD
Zalcitabine—Back pain—Doxorubicin—sarcoma	0.000252	0.000594	CcSEcCtD
Zalcitabine—Muscle spasms—Doxorubicin—sarcoma	0.00025	0.000591	CcSEcCtD
Zalcitabine—Palpitations—Epirubicin—sarcoma	0.000248	0.000587	CcSEcCtD
Zalcitabine—Loss of consciousness—Epirubicin—sarcoma	0.000247	0.000584	CcSEcCtD
Zalcitabine—Cough—Epirubicin—sarcoma	0.000245	0.000579	CcSEcCtD
Zalcitabine—Vision blurred—Doxorubicin—sarcoma	0.000245	0.000579	CcSEcCtD
Zalcitabine—Convulsion—Epirubicin—sarcoma	0.000244	0.000575	CcSEcCtD
Zalcitabine—Hypertension—Epirubicin—sarcoma	0.000243	0.000573	CcSEcCtD
Zalcitabine—Ill-defined disorder—Doxorubicin—sarcoma	0.000241	0.00057	CcSEcCtD
Zalcitabine—Anaemia—Doxorubicin—sarcoma	0.00024	0.000568	CcSEcCtD
Zalcitabine—Myalgia—Epirubicin—sarcoma	0.000239	0.000565	CcSEcCtD
Zalcitabine—Arthralgia—Epirubicin—sarcoma	0.000239	0.000565	CcSEcCtD
Zalcitabine—Agitation—Doxorubicin—sarcoma	0.000239	0.000565	CcSEcCtD
Zalcitabine—Anxiety—Epirubicin—sarcoma	0.000238	0.000563	CcSEcCtD
Zalcitabine—Discomfort—Epirubicin—sarcoma	0.000236	0.000558	CcSEcCtD
Zalcitabine—Malaise—Doxorubicin—sarcoma	0.000235	0.000554	CcSEcCtD
Zalcitabine—Dry mouth—Epirubicin—sarcoma	0.000234	0.000553	CcSEcCtD
Zalcitabine—Vertigo—Doxorubicin—sarcoma	0.000234	0.000552	CcSEcCtD
Zalcitabine—Syncope—Doxorubicin—sarcoma	0.000233	0.000551	CcSEcCtD
Zalcitabine—Leukopenia—Doxorubicin—sarcoma	0.000233	0.00055	CcSEcCtD
Zalcitabine—Confusional state—Epirubicin—sarcoma	0.000231	0.000546	CcSEcCtD
Zalcitabine—Palpitations—Doxorubicin—sarcoma	0.00023	0.000543	CcSEcCtD
Zalcitabine—Oedema—Epirubicin—sarcoma	0.000229	0.000542	CcSEcCtD
Zalcitabine—Loss of consciousness—Doxorubicin—sarcoma	0.000229	0.00054	CcSEcCtD
Zalcitabine—Infection—Epirubicin—sarcoma	0.000228	0.000538	CcSEcCtD
Zalcitabine—Cough—Doxorubicin—sarcoma	0.000227	0.000536	CcSEcCtD
Zalcitabine—Shock—Epirubicin—sarcoma	0.000226	0.000533	CcSEcCtD
Zalcitabine—Convulsion—Doxorubicin—sarcoma	0.000225	0.000532	CcSEcCtD
Zalcitabine—Thrombocytopenia—Epirubicin—sarcoma	0.000225	0.000531	CcSEcCtD
Zalcitabine—Hypertension—Doxorubicin—sarcoma	0.000225	0.00053	CcSEcCtD
Zalcitabine—Tachycardia—Epirubicin—sarcoma	0.000224	0.000529	CcSEcCtD
Zalcitabine—Skin disorder—Epirubicin—sarcoma	0.000223	0.000526	CcSEcCtD
Zalcitabine—Hyperhidrosis—Epirubicin—sarcoma	0.000222	0.000524	CcSEcCtD
Zalcitabine—Myalgia—Doxorubicin—sarcoma	0.000221	0.000523	CcSEcCtD
Zalcitabine—Arthralgia—Doxorubicin—sarcoma	0.000221	0.000523	CcSEcCtD
Zalcitabine—Anxiety—Doxorubicin—sarcoma	0.000221	0.000521	CcSEcCtD
Zalcitabine—Discomfort—Doxorubicin—sarcoma	0.000219	0.000517	CcSEcCtD
Zalcitabine—Anorexia—Epirubicin—sarcoma	0.000219	0.000517	CcSEcCtD
Zalcitabine—Dry mouth—Doxorubicin—sarcoma	0.000217	0.000512	CcSEcCtD
Zalcitabine—Confusional state—Doxorubicin—sarcoma	0.000214	0.000506	CcSEcCtD
Zalcitabine—Oedema—Doxorubicin—sarcoma	0.000212	0.000501	CcSEcCtD
Zalcitabine—Infection—Doxorubicin—sarcoma	0.000211	0.000498	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000209	0.000494	CcSEcCtD
Zalcitabine—Shock—Doxorubicin—sarcoma	0.000209	0.000493	CcSEcCtD
Zalcitabine—Thrombocytopenia—Doxorubicin—sarcoma	0.000208	0.000491	CcSEcCtD
Zalcitabine—Insomnia—Epirubicin—sarcoma	0.000207	0.00049	CcSEcCtD
Zalcitabine—Tachycardia—Doxorubicin—sarcoma	0.000207	0.000489	CcSEcCtD
Zalcitabine—Skin disorder—Doxorubicin—sarcoma	0.000206	0.000487	CcSEcCtD
Zalcitabine—Hyperhidrosis—Doxorubicin—sarcoma	0.000205	0.000485	CcSEcCtD
Zalcitabine—Dyspnoea—Epirubicin—sarcoma	0.000205	0.000483	CcSEcCtD
Zalcitabine—Somnolence—Epirubicin—sarcoma	0.000204	0.000482	CcSEcCtD
Zalcitabine—Anorexia—Doxorubicin—sarcoma	0.000202	0.000478	CcSEcCtD
Zalcitabine—Dyspepsia—Epirubicin—sarcoma	0.000202	0.000477	CcSEcCtD
Zalcitabine—Decreased appetite—Epirubicin—sarcoma	0.000199	0.000471	CcSEcCtD
Zalcitabine—Fatigue—Epirubicin—sarcoma	0.000198	0.000467	CcSEcCtD
Zalcitabine—Pain—Epirubicin—sarcoma	0.000196	0.000463	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000193	0.000457	CcSEcCtD
Zalcitabine—Insomnia—Doxorubicin—sarcoma	0.000192	0.000453	CcSEcCtD
Zalcitabine—Dyspnoea—Doxorubicin—sarcoma	0.000189	0.000447	CcSEcCtD
Zalcitabine—Feeling abnormal—Epirubicin—sarcoma	0.000189	0.000447	CcSEcCtD
Zalcitabine—Somnolence—Doxorubicin—sarcoma	0.000189	0.000446	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Epirubicin—sarcoma	0.000188	0.000443	CcSEcCtD
Zalcitabine—Dyspepsia—Doxorubicin—sarcoma	0.000187	0.000441	CcSEcCtD
Zalcitabine—Decreased appetite—Doxorubicin—sarcoma	0.000185	0.000436	CcSEcCtD
Zalcitabine—Fatigue—Doxorubicin—sarcoma	0.000183	0.000432	CcSEcCtD
Zalcitabine—Urticaria—Epirubicin—sarcoma	0.000182	0.00043	CcSEcCtD
Zalcitabine—Pain—Doxorubicin—sarcoma	0.000182	0.000429	CcSEcCtD
Zalcitabine—Body temperature increased—Epirubicin—sarcoma	0.000181	0.000428	CcSEcCtD
Zalcitabine—Abdominal pain—Epirubicin—sarcoma	0.000181	0.000428	CcSEcCtD
Zalcitabine—Feeling abnormal—Doxorubicin—sarcoma	0.000175	0.000413	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000174	0.00041	CcSEcCtD
Zalcitabine—Hypersensitivity—Epirubicin—sarcoma	0.000169	0.000399	CcSEcCtD
Zalcitabine—Urticaria—Doxorubicin—sarcoma	0.000169	0.000398	CcSEcCtD
Zalcitabine—Abdominal pain—Doxorubicin—sarcoma	0.000168	0.000396	CcSEcCtD
Zalcitabine—Body temperature increased—Doxorubicin—sarcoma	0.000168	0.000396	CcSEcCtD
Zalcitabine—Asthenia—Epirubicin—sarcoma	0.000165	0.000389	CcSEcCtD
Zalcitabine—Pruritus—Epirubicin—sarcoma	0.000162	0.000383	CcSEcCtD
Zalcitabine—Diarrhoea—Epirubicin—sarcoma	0.000157	0.000371	CcSEcCtD
Zalcitabine—Hypersensitivity—Doxorubicin—sarcoma	0.000156	0.000369	CcSEcCtD
Zalcitabine—Asthenia—Doxorubicin—sarcoma	0.000152	0.00036	CcSEcCtD
Zalcitabine—Dizziness—Epirubicin—sarcoma	0.000152	0.000358	CcSEcCtD
Zalcitabine—Pruritus—Doxorubicin—sarcoma	0.00015	0.000355	CcSEcCtD
Zalcitabine—Vomiting—Epirubicin—sarcoma	0.000146	0.000345	CcSEcCtD
Zalcitabine—Diarrhoea—Doxorubicin—sarcoma	0.000145	0.000343	CcSEcCtD
Zalcitabine—Rash—Epirubicin—sarcoma	0.000145	0.000342	CcSEcCtD
Zalcitabine—Dermatitis—Epirubicin—sarcoma	0.000145	0.000341	CcSEcCtD
Zalcitabine—Headache—Epirubicin—sarcoma	0.000144	0.000339	CcSEcCtD
Zalcitabine—Dizziness—Doxorubicin—sarcoma	0.00014	0.000332	CcSEcCtD
Zalcitabine—Vomiting—Doxorubicin—sarcoma	0.000135	0.000319	CcSEcCtD
Zalcitabine—Rash—Doxorubicin—sarcoma	0.000134	0.000316	CcSEcCtD
Zalcitabine—Dermatitis—Doxorubicin—sarcoma	0.000134	0.000316	CcSEcCtD
Zalcitabine—Headache—Doxorubicin—sarcoma	0.000133	0.000314	CcSEcCtD
